Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects

• Status: Completed
• Trial end date: 2022-01-12
• Target enrollment: 0
• Participant gender: Male

Summary

Skin Irritation and Phototoxicity Study of KX01 Ointment 1% in Japanese healthy male subjects

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: PharmaEssentia
• Collaborator: PharmaEssentia Japan K.K.

Criteria

Inclusion Criteria:

• Healthy Japanese male adult, whose age 20-65 years old

Exclusion Criteria:

• History of photosensitivity or photoallergy